GyroGear, founded by Dr Faii Ong, received $4.3M (equivalent to £3.1M) in phase one of its seed funding round led by Foxconn Technology Group for its flagship product GyroGlove, the world’s first wearable neuromuscular medical device.
Dr Ong has been dedicated to improve the lives of those who suffer from hand tremor due to nerve disorders such as Parkinson’s Disease and essential tremor. Given the uncontrollable shaking, hand tremor makes simple daily tasks difficult to be carried out, leaving patents with frustrations or even mental traumas. After presenting his idea in the Imperial Venture Catalyst Challenge in 2014 as a medical student, he founded GyroGear in 2016 upon to develop a wearable medical device incorporated with satellite-grade mechanical gyroscope through clinical trials. The company received €1.8M from the EU’s Horizon 2020 programme and represented Imperial at the World Economic Forum and the Falling Walls Venture as finalist in 2018.
The additional investment will be used for further rearch and development. With the support and access to class-leading technology from Foxconn Technology, GyroGlove will be closing an important gap in the medical field, helping to address pressing needs and bringing hope to over 2 millions of patents around the world.
Find out more about Imperial’s flagship entrepreneurial competition, the Venture Catalyst Challenge, and more news about GyroGear.
